A Phase 2/3 interventional study of rehabilitation and Acupuncture in Shoulder-hand Syndrome, sponsored by Zouqin Huang. Status unknown at 1 site in China. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2013-12-13.
Sponsored by Zouqin Huang · Phase 2/3, Interventional, and Treatment
Shoulder-hand syndrome,a common complication of stroke patient,which is an important factor of limb function recovery.This research aims to observe the effect and safety of Acupuncture and Traditional Chinese medicine Combined with Rehabilitation Therapy for Post-stroke Shoulder-hand Syndrome.Furthermore, the investigators will promote the treatment in community hospital.
149 studies on the registry are indexed under Reflex Sympathetic Dystrophy; 28 are open to participants now.
This study's planned enrollment of 90 is above the median of 40 across 114 interventional studies indexed under Reflex Sympathetic Dystrophy.
Browse Reflex Sympathetic Dystrophy studies →This is the only study on the registry with Zouqin Huang as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Electric acupuncture,Chinese medicine,Chinese medicine cupping,rehabilitation,To treat five times a week,Total course is eight weeks
Device: rehabilitation · Device: Acupuncture
rehabilitation,To treat five times a week,Total course is eight weeks
Device: rehabilitation
rehabilitation,To treat five times a week,Total course is eight weeks
Visual analogue scale (VAS) method Visual analogue scale (VAS) method Visual analogue scale (VAS)
To evaluate the pain in shoulder joint
Time frame: 4 weeks and 8 weeks after treatment
Fugl-Meyer scale
To evaluate the limb movement function
Time frame: 4 weeks and 8 weeks after treatment
Barthel index (BI)
To evaluate patient's ability in daily life
Time frame: 4 weeks and 8 weeks after treatment
This study is status unknown, as verified in Dec 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.